Chromogranin A
0080469
Ordering Recommendation
Assay aids in monitoring but is not recommended for diagnosis of carcinoid tumors. Assay may be useful in monitoring nonsecretory sympathetic and parasympathetic  neuroendocrine tumors.
Mnemonic
CGA SERUM
Methodology
Quantitative Enzyme Immunoassay
Performed
Mon, Wed, Fri
Reported
1-6 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Serum separator tube or plain red.  
Specimen Preparation
Allow serum specimen to clot completely at room temperature. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Frozen.  
Unacceptable Conditions
Plasma.  
Remarks
  
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 6 weeks  
Reference Interval
Effective May 16, 2011

0-95 ng/mL  
Interpretive Data
This test is performed using the Cisbio Chromoa EIA. Results obtained with different methods or kits cannot be used interchangeably.

See Compliance Statement D: www.aruplab.com/CS
Statement D: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
 
Note
 
CPT Code(s)
86316
Components
Component Test Code*Component Chart NameLOINC
0080469Chromogranin A9811-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • CgA